旨在调查中低收入国家慢性和急性病药品可获得性的潜在差异。
To investigate potential differences in the availability of medicines for chronic and acute conditions in low - and middle-income countries.
当前的疾病模式无法解释所观察到的慢性和急性病药品可获得性的重大差距。
Current disease patterns do not explain the significant gaps observed in the availability of medicines for chronic and acute conditions.
作为提高药品可获得性最为直接有效的方式，药品专利强制许可被推向了论战的风口浪尖。
Compulsory license of pharmaceutical patents, as the most effective method to promote access to medicines, becomes the focus of the debate.
尽管人们几乎没有进行过全面的研究，但是华盛顿大学的一项研究调查了药品样本的可获得性对医生开的处方的影响。
Though few comprehensive studies have been conducted, one by the University of Washington investigated how drug sample availability affected what physicians prescribe.
急性和慢性病药品的可获得性在各个国家均处于次优水平,特别是在公立部门。
The availability of medicines for both acute and chronic conditions was suboptimal across countries, particularly in the public sector.
喀土穆基本药品的可获得性较高(97%)，这一点应归功于药品周转基金。
Khartoum state has a high (97%) level of availability of essential medicines and this is attributed to the RDF.
低收入和中下收入国家公立部门急性病药品的可获得性比慢性病药品的可获得性分别高出33.9%和12.9%。
In low - and lower-middle income countries, drugs for acute conditions were 33.9% and 12.9% more available, respectively, in the public sector than medicines for chronic conditions.
ARV药物的价格已经明显下降，采购体制也得到了改善，生物药品的可获得性也有所改善。
ARV prices have dropped significantly and procurement systems have improved, as has generic drug availability.
目的：为在公共健康危机发生时，能有效降低专利药品价格，提高药品的可获得性。
OBJECTIVE: to lower the price of patent medicine effectively and to increase the access to medicine when public health crises occur.
目的：为在公共健康危机发生时，能有效降低专利药品价格，提高药品的可获得性。
OBJECTIVE: to lower the price of patent medicine effectively and to increase the access to medicine when public health crises occur.
应用推荐